Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 1 2Phase 1/2 1

Status

Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2CNS 1

Conditions

Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 4Neuroblastoma 2Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Lung Neoplasms 2Glioblastoma 2Recurrence 1Lymphoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Castration-resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Advanced Cancers 1Advanced Cancer 1Adenocarcinoma 1

Interventions

Cyclophosphamide 14fludarabine phosphate 9Bortezomib 9Brentuximab Vedotin 7Filgrastim 6Vorinostat 5Doxorubicin 5tanespimycin 4Whole-Body Irradiation 4Vincristine 4Peripheral Blood Stem Cell Transplantation 4Paclitaxel 4Gemcitabine 4Cyclosporine 4Cord Blood Stem Cell Transplantation 4Carboplatin 4Biopsy 4sargramostim 3romidepsin 3fludarabine 3Topotecan 3Rifampin 3Prednisone 3Mycophenolic Acid 3Magnetic Resonance Spectroscopy 3Leucovorin 3Lenalidomide 3Irinotecan 3Fluorouracil 3Everolimus 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, Large-Cell, Anaplastic × Crizotinib × Clear all
NCT01606878 2024-01-05

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Children's Oncology Group

Phase 1 Completed
46 enrolled 24 charts
CNSLymphoid

Neuroblastoma, Lymphoma, Large-Cell, Anaplastic

NCT00585195 2023-02-08

PROFILE 1001

Pfizer

Phase 1 Completed
596 enrolled 81 charts
Lymphoid

Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡